FDA DTC Ad Study: Firms Win Small Concession; Viewings Will Be Less Dense
This article was originally published in The Pink Sheet Daily
Executive Summary
AbbVie, Valeant and Lilly had critiqued proposed study to assess impact of repeated exposure to direct-to-consumer drug ads on perception of risks and benefits.